A5001877391- Retinal and Macular Surgery
- Retinal Diseases and Treatments
- Intraocular Surgery and Lenses
- Glaucoma and retinal disorders
- Retinal and Optic Conditions
- Retinal Imaging and Analysis
- Vascular Malformations Diagnosis and Treatment
- Retinal Development and Disorders
- Ocular Diseases and Behçet’s Syndrome
- Corneal surgery and disorders
- Ocular Infections and Treatments
- Ocular Disorders and Treatments
- Optical Coherence Tomography Applications
- Ophthalmology and Visual Impairment Studies
- Traumatic Ocular and Foreign Body Injuries
- Corneal Surgery and Treatments
- Ocular Oncology and Treatments
- Vascular Malformations and Hemangiomas
- Skin Protection and Aging
- Systemic Lupus Erythematosus Research
- Ocular Surface and Contact Lens
- Biosimilars and Bioanalytical Methods
- Ophthalmology and Eye Disorders
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Nephrotoxicity and Medicinal Plants
University of Brescia
2024
Ospedale Sant'Anna
2014-2022
University of Padua
2022
Ospedale Sacro Cuore Don Calabria
2009-2011
The Dia Foundation for Research on Ageing Societies
2011
Montefiore Hospital
2009
University of Verona
1998-2001
Rutgers New Jersey Medical School
1998
To correlate clinical and optical coherence tomographic (OCT) features with morphologic immunohistochemical findings of epiretinal membranes (ERMs) in lamellar macular holes (LMHs).Nineteen specimens were removed from 19 eyes during vitrectomy for hole ERM internal limiting membrane peeling, processed transmission electron microscopy immunohistochemistry by cross-sectional flat-mount preparation techniques. By using OCT criteria intraoperative observations, divided into two groups: 13...
To describe a comprehensive OCT-based classification of myopic traction maculopathy (MTM).Two hundred eighty-one eyes with MTM (visited from 2006 to 2018), were retrospectively reviewed for age, best-corrected-visual-acuity (BCVA), axial length (AL), optical coherence tomography (OCT), and wide-field color fundus-photographs. The study was divided in two Phases. Phase 1: types categorized OCT correlated age BCVA. type staphyloma described. 2: the evolution studied evaluating at least three...
To report the results of a retrospective analysis among endogenous uveitis patients in north-eastern area Italy.The authors reviewed series 655 new cases treated between October 1986 and December 1993. The incidence was calculated based on 100,000 patient population.The average 11.40/100,000. majority were ages 20 70 years (74.43%). A probable diagnosis determined 55.57% cases; anterior diagnosed 58.01% cases, posterior 26.11%, panuveitis 12.98%, intermediate 2.9% cases. observed recurrences...
The high concentration of carotenoids in the macula, plus evidence linking oxidative stress to age-related macular degeneration (AMD) and antioxidation, generated hypothesis that higher antioxidant intakes can prevent AMD. aim this study was determine whether nutritional supplementation with a targeted supplement improves visual acuity function AMD.In multicenter, prospective open-label randomized study, 145 patients were randomly assigned 2 different treatment groups. Interventions lutein...
Purpose. More than ten years after ETDRS, Optical Coherence Tomography (OCT) greatly enhanced our ability to detect macular thickening and has brought new insights on the morphology of edema presence vitreal traction. In this study we propose a classification based OCT findings better catalogue follow complex clinical entity. Methods. Since January 2000 analysed with 2 (Zeiss Inc.) more one thousand two hundred eyes DME. Results. The takes into account five parameters: retinal thickness,...
In Brief Background: To report the rate of postoperative complications in 943 consecutive eyes operated on with 23-gauge transconjunctival pars plana vitrectomy. Methods: Single-center, retrospective, noncomparative, interventional case series. Nine hundred and forty-three underwent core peripheral vitrectomy laser at sclerotomy sites from May 2005 through April 2008. The main outcome measures were intraocular pressure 1 day week intra- least 6-month follow-up. Results: Eight thirty-one...
The efficacy of a macular buckle in treating myopic traction maculopathy was studied.Fifty eyes with maculopathy, the form detachment hole (MHMD), or without (MD) and foveoschisis (MF), were treated vitrectomy combined vitrectomy.Combined group: group comprised 10 MHMD, 6 MD, 4 MF. retina attached 100% MD MHMD MF improved cases. closed 60% MHMD. mean initial final Snellen best-corrected visual acuity 20/500 20/100 for 20/200 20/60 20/50 surgical time 80 ± 35 minutes. Fundus angiography...
To report the long-term anatomical and functional results of macular buckle for Myopic Traction Maculopathy (MTM) in stages 3a, 3b, 4a, 4b according to MTM Staging System (MSS).
Purpose To describe the efficacy and safety outcomes of NPB ® macular buckle (MB) in myopic traction maculopathy (MTM). Methods A monocentric, prospective cohort study naïve eyes who underwent MB surgery, alone or combined with pars plana vitrectomy (PPV) for MTM, using new buckle, between December 2022 June 2024. The anatomical results, postoperative complications, ease use were analyzed as main outcomes. Secondary included changes best-corrected visual acuity (BCVA), axial length (AL),...
Purpose: To report the anatomic and visual outcomes of eyes developing delayed rhegmatogenous retinal detachment (RRD) post macular surgery. Methods: This was a retrospective, multicentric study including undergoing RRD repair at least 3 months after surgery for either full-thickness hole (FTMH) or epiretinal membrane (ERM). Anatomic functional assessment, i.e., pre- post-operative best corrected acuity (BCVA), indications details surgery, time interval from to RRD, intraocular tamponade,...
To assess the awareness of biosimilar intravitreal anti-VEGF agents among retina specialists practicing in United States (US) and Europe.A 16-question online survey was created English distributed between Dec 01, 2021 Jan 31, 2022. A total 112 respondents (retinal physicians) from US Europe participated.The majority physicians (56.3%) were familiar with biosimilars. significant number needed more information (18.75%) real world data (25%) before switching to a biosimilar. About one half...